Table 2.
The average number of documents submitted and the total number of pages in the GMO dossier for Pfizer AAV investigational compounds
| Country | Number of investigational compounds participated | Number of documents submitted (±SD) | Average of total pages for GMO application (±SD) |
|---|---|---|---|
| Belgium | 2 | 14.0 (±1.4) | 343.0 (±62.2) |
| France | 3 | 13.0 (±3.5) | 266.5 (±68.8) |
| Germany | 3 | 4.3 (±0.6) | 96.3 (±31.6) |
| Greece | 2 | 3.0 (±0) | 122.5 (±0.7) |
| Italy | 2 | 2.0 (±0) | 65.0 (±2.8) |
| Japan | 3 | 3.0 (±0) | 72.0 (±9.7) |
| Spain | 3 | 12.7 (±1.5) | 313.0 (±14.8) |
| Sweden | 2 | 4.0 (±0) | 123.5 (±0.7) |
Each value represents the average number of documents and total number of pages for GMO dossiers submitted for Pfizer investigational compounds undergoing GMO approval. Data are presented as mean ± SD.
AAV, adeno-associated virus.